WallStreetZenWallStreetZen

NASDAQ: NPCE
Neuropace Inc Stock Forecast, Predictions & Price Target

Analyst price target for NPCE

Based on 5 analysts offering 12 month price targets for Neuropace Inc.
Min Forecast
$13.00+74.73%
Avg Forecast
$18.00+141.94%
Max Forecast
$22.00+195.7%

Should I buy or sell NPCE stock?

Based on 5 analysts offering ratings for Neuropace Inc.
Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NPCE stock forecasts and price targets.

NPCE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-09
lockedlocked$00.00+00.00%2024-03-14
lockedlocked$00.00+00.00%2024-03-12
lockedlocked$00.00+00.00%2024-03-06
lockedlocked$00.00+00.00%2024-01-30

1 of 1

Forecast return on equity

Is NPCE forecast to generate an efficient return?
Company
-56.17%
Industry
27.02%
Market
80.58%
NPCE's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NPCE forecast to generate an efficient return on assets?
Company
-8.15%
Industry
14.18%
NPCE is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NPCE earnings per share forecast

What is NPCE's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.14
Avg 2 year Forecast
-$1.10
Avg 3 year Forecast
-$0.86

NPCE revenue forecast

What is NPCE's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$75.8M+9.77%
Avg 2 year Forecast
$88.1M+27.6%
Avg 3 year Forecast
$103.2M+49.39%
NPCE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NPCE revenue growth forecast

How is NPCE forecast to perform vs Medical Devices companies and vs the US market?
Company
14.15%
Industry
8.21%
Market
10.62%
NPCE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NPCE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NPCE vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
NPCE$7.44$18.00+141.94%Strong Buy
INGN$9.01$7.00-22.31%Hold
OM$4.20$6.00+42.86%Strong Buy
CVRX$9.72$13.80+41.98%Strong Buy
CLPT$7.52$9.00+19.68%Strong Buy

Neuropace Stock Forecast FAQ

Is Neuropace Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: NPCE) stock is to Strong Buy NPCE stock.

Out of 5 analysts, 3 (60%) are recommending NPCE as a Strong Buy, 1 (20%) are recommending NPCE as a Buy, 1 (20%) are recommending NPCE as a Hold, 0 (0%) are recommending NPCE as a Sell, and 0 (0%) are recommending NPCE as a Strong Sell.

If you're new to stock investing, here's how to buy Neuropace stock.

What is NPCE's earnings growth forecast for 2024-2026?

(NASDAQ: NPCE) Neuropace's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.78%.

Neuropace's earnings in 2024 is -$31,506,000.On average, 4 Wall Street analysts forecast NPCE's earnings for 2024 to be -$32,867,586, with the lowest NPCE earnings forecast at -$34,521,754, and the highest NPCE earnings forecast at -$31,357,260. On average, 3 Wall Street analysts forecast NPCE's earnings for 2025 to be -$31,550,006, with the lowest NPCE earnings forecast at -$35,960,160, and the highest NPCE earnings forecast at -$27,617,403.

In 2026, NPCE is forecast to generate -$24,740,590 in earnings, with the lowest earnings forecast at -$26,178,996 and the highest earnings forecast at -$22,439,140.

What is NPCE's revenue growth forecast for 2024-2026?

(NASDAQ: NPCE) Neuropace's forecast annual revenue growth rate of 14.15% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.21%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Neuropace's revenue in 2024 is $69,073,000.On average, 3 Wall Street analysts forecast NPCE's revenue for 2024 to be $2,181,228,233, with the lowest NPCE revenue forecast at $2,176,884,246, and the highest NPCE revenue forecast at $2,188,506,569. On average, 3 Wall Street analysts forecast NPCE's revenue for 2025 to be $2,535,622,802, with the lowest NPCE revenue forecast at $2,457,431,030, and the highest NPCE revenue forecast at $2,609,556,891.

In 2026, NPCE is forecast to generate $2,968,611,896 in revenue, with the lowest revenue forecast at $2,704,865,699 and the highest revenue forecast at $3,137,164,358.

What is NPCE's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NPCE) forecast ROA is -8.15%, which is lower than the forecast US Medical Devices industry average of 14.18%.

What is NPCE's Price Target?

According to 5 Wall Street analysts that have issued a 1 year NPCE price target, the average NPCE price target is $18.00, with the highest NPCE stock price forecast at $22.00 and the lowest NPCE stock price forecast at $13.00.

On average, Wall Street analysts predict that Neuropace's share price could reach $18.00 by May 9, 2025. The average Neuropace stock price prediction forecasts a potential upside of 141.94% from the current NPCE share price of $7.44.

What is NPCE's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: NPCE) Neuropace's current Earnings Per Share (EPS) is -$1.18. On average, analysts forecast that NPCE's EPS will be -$1.14 for 2024, with the lowest EPS forecast at -$1.20, and the highest EPS forecast at -$1.09. On average, analysts forecast that NPCE's EPS will be -$1.10 for 2025, with the lowest EPS forecast at -$1.25, and the highest EPS forecast at -$0.96. In 2026, NPCE's EPS is forecast to hit -$0.86 (min: -$0.91, max: -$0.78).

What is NPCE's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NPCE) forecast ROE is -56.17%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.